Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Estimates of the means, medians and 95^th percentiles of incubation periods in the sensitivity analysis. by Li Li (14993)

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

OIP5-AS1 binds to miR-145-5p. by Jingyan Yang (7120994)

Time-dependent decrease of ln-transformed relative abundance of puparial hydrocarbons in <i>Chrysomya megacephala</i> during the 90-day weathering process, only for nine of those p... by Guang-Hui Zhu (454717)

SEM images (a) 5LZCM (b) 10LZCM (c) 15LZCM. by Md. Abu Daud (21485629)

A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy by Eric M. Davis (1733638)

“…After PAB, mice spent significantly more time in NREM sleep compared to the control group over a 24 hour period (53.5 ± 1.5% vs. 46.6 ± 1.4%; p < 0.01) and exhibited an inability to both cycle into REM sleep and decrease delta density across the light/sleep period. …”

Patients and Non-diabetic controls characteristics. by Lucy Baldeón R. (674016)

The proportion of participants who reported authorship (self, delay, or other). by Junhui Kim (18575083)

Subjects:

Fig 5 - by Kara Rising (14019980)

Overexpression of wild-type <i>BRAP</i> and p.Arg554Leu-<i>BRAP</i> variant decreased cell viability although this was less in cells expressing the p.Arg554Leu-<i>BRAP</i> variant. by Ayako Chida-Nagai (6281843)

Adjusted 5-year risk of cardiovascular diseases (CVD) under different levels of HbA1c-SD, FPG-SD, and HbA1c value, using parametric g-formula. by Khadije Maajani (10125692)

Models for changes in DNA methylation of the <i>WNT5A</i> promoter B region during progression of osteoblast cells to osteosarcoma. by Himani Vaidya (3179403)

“…B) NCBI Epigenomics search for CTCF binding in the <i>WNT5A</i> genomic region of human osteoblasts. Location of the CpG regions R3, R4, and R5 are indicated, along with promoter A exon 1 (box) and promoter B exon 1β (box at arrow). …”

Dendrogram of unsupervised hierarchical cluster analysis of the tested serum levels of microRNAs, cytokines, chemokines and growth factors in T2D patients and Non-diabetic controls... by Lucy Baldeón R. (674016)

Cytokines, chemokines and growth factors in Non-diabetic controls and T2D patients. by Lucy Baldeón R. (674016)

A higher mean amplitude or lower standard deviation of the EOD of the swimming fish facilitates estimation of beat frequency at the receptor level. by Na Yu (151735)

“…Therefore (C), the height-to-width ratio of this peak slightly increases with , while (D) it decreases rapidly with . The curves in this figure and next figure are the average results over five artificial signals with  = [827,737], [827,760], [827,792], [827,704], [740,807]Hz; 50 independent OU processes were used to calculate the average for each artificial signal.…”

Inactivation of the <i>WNT5A</i> Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2 by Himani Vaidya (3179403)

“…<div><p><i>WNT5A</i> is a secreted ligand involved in Wnt pathway signaling and has a role in cell movement and differentiation. …”

Alprenolol-biotin binding in subsets of peripheral blood cells is decreased in PAH as compared to controls. by Jonathan A. Rose (2822210)

Interactions between sward heights of Kikuyu grass and time of day and period of evaluation. by Alejandra Marín Gómez (13020659)